BIOREGULATORY DRUGS FOR ACUTE RESPIRATORY VIRAL INFECTIONS IN CHILDREN

DOI: https://doi.org/10.29296/25877305-2018-03-22
Download full text PDF
Issue: 
3
Year: 
2018

S. Krutikhina, E. Yablokova, Candidate of Medical Sciences I.M. Sechenov First Moscow State Medical University (Sechenov University)

Frequent acute respiratory viral infections (6-10 episodes per year) in many children require the use of various medications, which leads to immunological tolerance. Their efficient and cost-effective replacement (or complement to drug therapy) is the combination bioregulatory medications manufactured by the company Heel.

Keywords: 
therapy
children
acute respiratory viral infections
bioregulatory drugs



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Briko N.I. Kliniko-epidemiologicheskaja harakteristika grippa i ORVI i napravlenija ih profilaktiki // Meditsinskaja sestra. – 2013; 8: 16–23.
  2. Bulgakova V.A. Ostrye respiratornye infektsii u detej: ratsional'nyj vybor farmakoterapii // Spravochnik pediatra. – 2011; 8: 28–37.
  3. Grigor'ev K.I., Vyhristjuk O.F., Rahmetullova G.R. Rekurrentnye respiratornye infektsii u chasto bolejuschih detej // Meditsinskaja sestra. – 2015; 8: 28–34.
  4. Zaplatnikov A.L., Korovina N.A., Burtseva E.I. Sovremennye preparaty, soderzhaschie sverhmalye dozy dejstvujuschego veschestva, i traditsionnye gomeopaticheskie sredstva v profilaktike i lechenii ORVI i grippa u detej // Pediatrija. – 2009; 87 (1): 95–100.
  5. Mar'janovskij A.A. Osobennosti kompleksnoj terapii rinosinusitov preparatami na osnove natural'nyh komponentov // RMZh. – 2016; 3: 140–2.